AUTHOR AND EDITOR INFORMATION

Section 1 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

INTRODUCTION

Section 2 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Background

Holt-Oram syndrome (HOS) (OMIM 142900) is a heart–upper limb malformation complex with an autosomal dominant inheritance and near-complete penetrance but variable expression. Holt and Oram first described this syndrome in 1960. Approximately 40% of cases represent new mutations.

Pathophysiology

Defective development of the embryonic radial ray (eg, aplasia, hypoplasia, fusion, other anomalous development) results in a wide spectrum of phenotypes, including triphalangeal or absent thumbs, foreshortened arms, and phocomelia. The syndrome is associated with defective development of cardiac structures that results in atrial septal defect (ASD), most commonly the secundum type; heart block of varying degree; or both.  

The responsible gene has been mapped to band 12q24.1, which encodes the human transcription factor TBX5. A full list of the described mutations is available at the TBX5 Gene Mutation Database, an online locus-specific database that contains germline and somatic mutations of the TBX5 gene. One of the recently added loci is c.373G>A, which results in the missense mutation p.Gly125Arg; this is a novel mutation, in that it is associated with a gain-of-function mechanism and is associated with paroxysmal atrial fibrillation and no structural heart disease.¹

TBX5 genotyping has high sensitivity and specificity for HOS if stringent diagnostic criteria are used in assigning the clinical diagnosis. Mutations of this gene introduce a premature stop codon and result in truncated protein versions. Consequent abnormal expression of the cardiac and limb-specific T-box transcription factors lead to the malformations described in HOS. The T-box gene family is a group of related genes that play a critical role in human embryonic development.

A cardiomelic developmental field has also been postulated to relate the genetic heterogeneity of HOS (and other similar syndromes) to a cascade of molecules, including the brachyury, sonic hedgehog, bone morphogenetic protein, retinoic acid receptor, and transforming growth factor beta families.

Disturbed fetal limb muscle development has also been reported and may underlie the bony malformations.

Expression widely varies in different generations. Ogur et al reported variable clinical expression of HOS in 3 generations.² The grandfather presented with phocomelia of arms, with 3 digits on each hand, congenital heart defect, and narrow shoulders. His son presented with cardiac conduction disturbance with no congenital heart or skeletal defect. His granddaughter developed ventricular septal defect (VSD) and moderate radial deviations of both hands, with no obvious hypoplasia of the extremities. Cachat et al reported a father and 2 sons in a French family with HOS who presented with different types of atrial septal defects (ASD): ostium primum ASD, secundum ASD, and sinus venosus ASD, respectively.

Frequency

United States

The incidence rate is unknown.

International

In Hungary, the birth prevalence is 0.95 per 100,000 total births. About 350 cases have been reported worldwide. A recent report identified this syndrome in 4% of patients with radial longitudinal deficiency.³

Mortality/Morbidity

No valid figures are available because the condition, in and of itself, has no specific mortality or morbidity. The mortality and morbidity relate directly to the associated congenital abnormalities, particularly those of the heart. For example, mortality and morbidity of a secundum ASD is negligible throughout childhood, including patients who undergo procedures to close the ASD. Please see the appropriate respective articles for mortality and morbidity figures on specific cardiac defects.

Causes of death include cardiac malformation and heart block. See the respective article for each cardiac abnormality for a discussion of cause of death.

Race

No valid data are available.

Sex

Both sexes are equally affected, although the defects tend to be more severe in females.

Age

Malformations are present at birth. Age at presentation varies according to the extent of the abnormality externally visible and the type of associated heart defect, if any.

CLINICAL

Section 3 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

History

• Clinical features of Holt-Oram syndrome (HOS) vary depending on the severity of the cardiac and limb malformation.
• Individuals with more severe congenital heart defects may present in the neonatal period. Abnormalities may also be detected in utero using fetal ultrasonography and fetal echocardiography.
• Cardiac symptoms depend on the type of congenital heart defect. Atrial septal defect (ASD), the most common heart defect in HOS, causes no symptoms in the vast majority of affected individuals.
• Severity of cardiac and limb malformations appears to be positively correlated in some studies; however, this has not been replicated in other studies.
• In any sporadic case of ASD, the patient and parents should be examined for limb malformations, and the family history should be studied in detail.

Physical

Physical findings may include the following:

• Musculoskeletal defects
• • Upper limbs are usually affected, although the importance of isolated lower limb involvement associated with specific mutations has been reported.⁴
  • Although bilateral, the left side is often more significantly affected.
  • The most severe form is phocomelia with rudimentary limbs.
  • Mildest forms include clinodactyly, limited supination, and sloping shoulders.
  • The most common defects include radial thumb anomalies ranging from absent thumbs to displaced (distally placed), duplicated, or triphalangeal thumbs. Carpal and metacarpal anomalies (especially the fourth) may also be present.
  • Hypoplasia of the radius manifests as short deformed forearm, although it may be so mild that it is detectable only on radiography of the forearm.
  • Sprengel deformity (upward displacement of the scapula) and hypoplasia of the shoulders, clavicles, and humerus have also been reported.
  • The number and location of hypoplastic muscles correlate with the severity of skeletal involvement. Accordingly, patients with hypoplasia of large and proximal muscles have phocomelia, and those with intrinsic hand muscle hypoplasia have only a triphalangeal thumb or no skeletal malformation.
  • Associated muscular hypoplasia that involves the hypothenar, wrist extensor, supinator, biceps brachii, triceps brachii, deltoid, pectoral, and trapezium muscles has also been reported.
  • Isolated (sporadic) patients have more severe involvement, which can include the ulnar ray.
• Heart defects
• • The reported incidence ranges from 50-95%.
  • The most common lesion is a secundum ASD. Others include ventricular septal defect (VSD), atrioventricular (AV) block, pulmonic stenosis (including peripheral arterial), and mitral valve prolapse.
  • Approximately 17% of patients have more complex cardiac malformations, such as tetralogy of Fallot, hypoplastic left heart, endocardial cushion defects, and truncus arteriosus. Cardiac arrhythmias include paroxysmal tachycardia, prolonged PR interval, wandering atrial pacemaker, atrial ectopics, AV block, and sinus bradycardia. Syncope and sinus arrest have been reported. Multiple VSDs have also been reported.
  • According to Mglinets, "a specific feature of the syndrome is a change in the main palmar lines and their termination on the radial border of the hand not only in the absence of the thumb but also in the case of formation of the abortive xT-line, its radiants, and the axial triradius."⁵
  • Pulmonary hypoplasia has occasionally been reported and can present with neonatal respiratory distress.^{6, 7} No other associated visceral anomaly has been reported.
• Intelligence: Intelligence is normal.

A scoring system to assess severity has been recommended by Gall et al and modified by Gladstone and Sybert, as follows:

• Scoring system to assess skeletal abnormalities in HOS
• • 0 - No abnormality on physical or radiological examination
  • 1 - Minor abnormalities, including reduced thenar eminence, clinodactyly, or hypoplasia of the thumb
  • 3 - Present arms and forearms, with one or more bones missing
  • 4 – Phocomelia
• Scoring system to assess cardiac abnormalities in HOS
• • 0 - Asymptomatic, with no abnormal physical findings
  • 1 - Conduction defect
  • 2 - Structural heart abnormality that does not require surgery
  • 3 - Structural heart abnormality that requires surgery but is not life threatening
  • 4 - Potentially lethal malformation

DIFFERENTIALS

Section 4 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Other Problems to be Considered

The following syndromes do not include atrial septal defect (ASD) and do not map to band 12q2:

• Heart-hand syndrome type II (Tobatznik syndrome)
• Heart-hand syndrome type III (OMIM 140450)

• Okihiro/Duane-radial ray syndrome (DRRS)
• Coloboma, heart disease, atresia, choanae, retarded growth and retarded development and/or CNS anomalies, genital hypoplasia, and ear anomalies and/or deafness (CHARGE) association
• Fanconi anemia
• Thalidomide embryopathy
• Vertebral defects, imperforate anus, tracheoesophageal fistula, radial and renal dysplasia (VATER) and/or vertebral, anal, cardiac, tracheal, esophageal, renal, limb (VACTERL) association

WORKUP

Section 5 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Lab Studies

• Blood tests are required for molecular genetics in patients with Holt-Oram syndrome (HOS) and for management because the cardiac anomaly present may be a major one that causes and cause symptoms or requires intervention.

Imaging Studies

• Imaging studies of upper limbs
• • The scapula may be raised and small, with abnormalities at the acromial region, a prominent coracoclavicular joint, and a small glenoid fossa.
  • The humerus may be hypoplastic or absent in patients with phocomelia. In other patients, the medial epicondyles are large and the humeral head may be deformed with epiphyseal irregularities. Radioulnar and humeroulnar synostosis, radial hypoplasia or absence, and ulnar absence are all reported.
  • Scaphoid anomalies are particularly common and include hypoplasia and bipartite ossification. In the normal fetus, a scaphoid bone called the os central (representing a third row of carpal centres) usually fuses with the scaphoid, but this may not occur in patients with HOS.
  • Additional carpal bones may be present. Other carpal anomalies include absence, hypoplasia, enlargement, irregularity, and fusion.
  • The first through fifth metacarpals may have both proximal and distal epiphyses. Structural changes such as hypoplasia may be present.
• Chest radiography: Chest radiography findings are either normal or reflect the type of cardiac abnormality.
• Doppler-echocardiography (ECHO) evaluation
• • This study is used to reveal the primary heart defect, its severity, and associated cardiac malformations.
  • It also allows estimation of certain hemodynamic values, such as blood flow and chamber pressure. However, reliability of some of these measurements is limited.
  • Doppler ECHO is indicated in the newborn with a skeletal abnormality suggestive of HOS.
• MRI
• • This is helpful for delineating cardiac and skeletal involvement.
  • MRI may also be used to confirm muscular hypoplasia and to help distinguish the muscle involvement from those of any coexisting progressive neuromuscular disorders.

Other Tests

• Electrocardiography
• • This test reveals the features of the underlying heart defect. The most common defect, secundum ASD, usually demonstrates right atrial enlargement and right ventricular enlargement.
• • Cardiac rhythm disturbances include both tachyarrhythmia and bradyarrhythmia. Prominent among these are heart blocks (first-degree, second-degree, or third-degree), wandering atrial pacemaker, and sinus bradycardia.
• Twenty-four–hour Holter ECG
• • This test reveals paroxysmal tachycardia, especially atrial tachycardia. Occasional sinus pauses or sinus arrest is found.
• • This test is especially important in patients with a history of syncope.
• Karyotyping and molecular studies
• • Detailed cytogenetic analysis may help to map the breakpoints within the critical area of 12q.
• • This study requires a combination of chromosome painting and fluorescent in situ hybridization (FISH) with yeast artificial chromosomes (YAC) and cosmids.
• Prenatal diagnosis
• • Amniocentesis and chorionic villus biopsy may be indicated based on the family history.
  • Fetal ultrasonography may reveal a skeletal abnormality suggestive of HOS.
  • Prenatal diagnosis is feasible in families with HOS linked to band 12q2.
  • DNA-based diagnosis must be coupled with noninvasive fetal imaging techniques to define phenotypic manifestations.

Procedures

• Cardiac catheterization and angiography
  
  
  • These are performed in selected patients in whom echocardiographic findings are either inconclusive or more accurate hemodynamic assessment is considered necessary.
  • Findings reflect the specific cardiac abnormality.
  • Complications during the procedure may include blood vessel rupture, tachyarrhythmias, bradyarrhythmias, and vascular occlusion.
  • Postcatheterization problems include hemorrhage, vascular disruption after balloon dilation, pain, nausea and vomiting, and arterial or venous obstruction due to thrombosis or spasm.

TREATMENT

Section 6 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Medical Care

• Acute-stage management in patients with Holt-Oram syndrome (HOS)
• • Treatment is directed at the cardiac manifestations.
  • Establish a complete diagnosis.
  • Counsel the patient and family.

Surgical Care

• Treatment for the heart defect
• • Appropriate surgical or nonsurgical correction of the heart defect if indicated and possible
• • Palliative surgery, as indicated, if complete correction is not possible
• Treatment for musculoskeletal defects
• • Take adequate measures to prevent acquired deformities and to treat existing deformities.
  • Surgical management of hand anomalies depends on the age, pattern, and degree of accompanying malformations of the upper limb.
  • Pollicization to improve function of index finger is recommended for patients with aplasia of the thumb. This is also recommended following amputation of a rudimental thumb.

Consultations

• Pediatric cardiologist
• Orthopedic specialist
• Radiologist
• Nuclear medicine specialist
• Family physician
• Occupational therapist
• Physiotherapist
• Psychologist
• School teacher
• Specialist nurse
• Pharmacist
• Dietitian

Diet

• Diet may require modification because of the specific cardiac abnormality.

Activity

• No restrictions are required unless specific cardiac abnormality indicates otherwise.

MEDICATION

Section 7 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

The specific cardiac defect and its effects dictate appropriate therapy. For example, treatment of congestive heart failure may include diuretics, an ACE inhibitor, and digoxin. Iron supplements are appropriate in patients with cyanotic heart disease.

Bacterial endocarditis prophylaxis is administered to patients with Holt-Oram syndrome (HOS) based on the specific cardiac condition. An isolated secundum atrial septal defect (ASD) does not require this treatment. For more information, see Antibiotic Prophylactic Regimens for Endocarditis.

Drug Category: Diuretics

These agents eliminate retained fluid and lower preload.

Drug Category: ACE inhibitors

These agents reduce afterload and decrease myocardial remodeling that worsen chronic heart failure.

Drug Category: Cardiac glycosides

These agents improve symptoms, exert a positive inotropic effect on both the normal and failing heart, and are mediated through inhibition of transmembranous active transport of sodium and potassium. Clinically important actions are on the sinoatrial (SA) and AV nodes. Cardiac glycosides increase efferent vagal impulses, reflexly reduce sympathetic tone, and decrease the sinus rate. They decrease conduction velocity through the AV node.

Drug Category: Beta-adrenoceptor blockers

These agents relieve infundibular spasm in hypercyanotic spells.

FOLLOW-UP

Section 8 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Further Inpatient Care

• Care may be necessary with exacerbations of heart failure, for interventional procedures, or for surgical correction of heart disease.

Further Outpatient Care

• Regular follow-up is essential for both cardiac and skeletal conditions.
• The patient should be seen by orthopedic and occupational therapists, as well as by physiotherapists.
• At each visit, the importance of prevention of deformity must be emphasized.

In/Out Patient Meds

• Administer medications as dictated by the heart disease.

Transfer

• Transfer may be necessary for further evaluation and surgical intervention.

Deterrence/Prevention

• Avoid activity beyond tolerance.
• Avoid postures that might lead to deformities.

Complications

• Complications secondary to heart disease and heart failure: Tachyarrhythmia and conduction abnormalities place patients at special risk during anesthetic procedures.
• Complications secondary to limb malformation
  
  
  • Secondary to interventions that may be required
  • Contractures and deformity
• Psychological problems secondary to disability

Prognosis

• Prognosis is dictated by the severity and type of cardiac and limb malformations.
• A scoring system to assess severity has been recommended by Gall et al and modified by Gladstone and Sybert. This information is provided in the Physical section.

Patient Education

• Parents and patients should understand the various manifestations and should undergo genetic counseling.
• • In any child with ASD, the patient and parents should be carefully examined for limb malformations, and a family history should be studied in detail.
• • Detection of subtle limb defect alters the recurrence risk in offspring from the empirical risk of an isolated ASD (3%) to that for an autosomal dominant trait (50%).
• Prenatal counseling
• • Prospective parents should be alerted to the fact that a child born with HOS to an affected parent has a 1 in 3 chance of having a severe reduction abnormality of the upper limb, with a 1 in 22 risk of phocomelia.
  • If an ASD is present, the risk of serious limb abnormality is greater than if a VSD or conduction defect occurs alone.
  • Severity is likely to be greater if the transmitting parent is female.
  • The detection of a severe reduction defect before or after birth indicates a high probability of an associated structural cardiac lesion.

MISCELLANEOUS

Section 9 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Medical/Legal Pitfalls

• Failure to identify Holt-Oram syndrome (HOS)
• Failure to perform a cardiovascular evaluation in children with limb anomalies, even if they are minor
• Failure to inform parents about the hereditary nature of the disease and the risk of recurrence
• Failure to inform parents that the syndrome may be associated with complex heart disease

Special Concerns

• Among others, family doctors and schoolteachers should be informed of the limb deformity and the heart disease.
• Identification of a skeletal abnormality suggestive of HOS in a pregnant woman should prompt careful examination with fetal ultrasonography. Similarly, if routine fetal ultrasonography reveals suggestive skeletal abnormalities, careful fetal echocardiography is indicated. Routine neonatal echocardiography should be performed in newborns not previously suspected to have HOS but who, after birth, demonstrate skeletal abnormalities suggestive of HOS.

MULTIMEDIA

Section 10 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Media file 1:  Photograph showing hypoplastic right thumb of the right hand of a 6-month-old infant with Holt-Oram syndrome.
	View Full Size Image
Media type:  Photo

Media file 2:  Photograph of the left hand of a 6-month-old infant with Holt-Oram syndrome showing total aplasia of the left thumb.
	View Full Size Image
Media type:  Photo

Media file 3:  Plain radiograph of the right forearm and hand of a 5-month-old infant with Holt-Oram syndrome showing hypoplastic radius and ulna and only 4 metacarpals.
	View Full Size Image
Media type:  X-RAY

Media file 4:  A 2-dimensional echocardiographic picture taken from subxiphoid window showing a large secundum atrial septal defect (arrow) in a 7-year-old boy with Holt-Oram syndrome. ASD = Atrial septal defect; RA = Right atrium; RV = Right ventricle; LA = Left atrium; LV = Left ventricle.
	View Full Size Image
Media type:  Echo

Media file 5:  Color Doppler echocardiographic picture taken from subxiphoid window showing the large left-to-right flow of blood (arrow) across the atrial septal defect. The red color pattern depicts flow direction from left atrium (LA) to right atrium (RA). ASD = Atrial septal defect; RA = Right atrium; RV = Right ventricle; LA = Left atrium; LV = Left ventricle.
	View Full Size Image
Media type:  Echo

REFERENCES

Section 11 of 11

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

1. Postma AV, van de Meerakker JB, Mathijssen IB, et al. A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res. Jun 6 2008;102(11):1433-42. [Medline].
2. Ogur G, Gul D, Lenk MK, Imirzalioglu N, Alpay F, Ogur E. Variable clinical expression of Holt-Oram syndrome in three generations. Turk J Pediatr. Oct-Dec 1998;40(4):613-8. [Medline].
3. Goldfarb CA, Wall L, Manske PR, et al. Radial longitudinal deficiency: the incidence of associated medical and musculoskeletal conditions. J Hand Surg [Am]. Sep 2006;31(7):1176-82. [Medline].
4. Garavelli L, De Brasi D, Verri R, Guareschi E, Cariola F, Melis D, et al. Holt-Oram syndrome associated with anomalies of the feet. Am J Med Genet A. May 1 2008;146A(9):1185-9. [Medline].
5. Mglinets VA. [Hand dermatoglyphics in patients with isolated triphalangia and Holt-Oram syndrome]. Genetika. Aug 1995;31(8):1147-53. [Medline].
6. Tseng YR, Su YN, Lu FL, et al. Holt-Oram syndrome with right lung agenesis caused by a de novo mutation in the TBX5 gene. Am J Med Genet A. May 1 2007;143A(9):1012-4. [Medline].
7. Smets K, Mortier G, Zecic A. Perinatal/neonatal case presentation: unexpected severe respiratory insufficiency in a newborn with Holt-Oram Syndrome. J Perinatol. Nov 2005;25(11):745-6. [Medline].
8. Allanson JE, Newbury-Ecob RA. Holt-Oram syndrome: is there a "face"?. Am J Med Genet A. May 1 2003;118(4):314-8. [Medline].
9. Basson CT, Cowley GS, Solomon SD, et al. The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med. Mar 31 1994;330(13):885-91. [Medline]. [Full Text].
10. Basson CT, Huang T, Lin RC, et al. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A. Mar 16 1999;96(6):2919-24. [Medline]. [Full Text].
11. Basson CT, Solomon SD, Weissman B, et al. Genetic heterogeneity of heart-hand syndromes. Circulation. Mar 1 1995;91(5):1326-9. [Medline]. [Full Text].
12. Benson DW, Basson CT, MacRae CA. New understandings in the genetics of congenital heart disease. Curr Opin Pediatr. Oct 1996;8(5):505-11. [Medline].
13. Bohm M. Holt-Oram syndrome. Circulation. Dec 8 1998;98(23):2636-7. [Medline]. [Full Text].
14. Borozdin W, Bravo Ferrer Acosta AM, Bamshad MJ, et al. Expanding the spectrum of TBX5 mutations in Holt-Oram syndrome: detection of two intragenic deletions by quantitative real time PCR, and report of eight novel point mutations. Hum Mutat. Sep 2006;27(9):975-6. [Medline].
15. Borozdin W, Bravo-Ferrer Acosta AM, Seemanova E, et al. Contiguous hemizygous deletion of TBX5, TBX3, and RBM19 resulting in a combined phenotype of Holt-Oram and ulnar-mammary syndromes. Am J Med Genet A. Sep 1 2006;140(17):1880-6. [Medline].
16. Bossert T, Walther T, Gummert J, et al. Cardiac malformations associated with the Holt-Oram syndrome--report on a family and review of the literature. Thorac Cardiovasc Surg. Oct 2002;50(5):312-4. [Medline].
17. Brassington AM, Sung SS, Toydemir RM, et al. Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet. Jul 2003;73(1):74-85. [Medline]. [Full Text].
18. Brockhoff CJ, Kober H, Tsilimingas N, et al. Holt-Oram syndrome. Circulation. Mar 16 1999;99(10):1395-6. [Medline]. [Full Text].
19. Bruneau BG, Logan M, Davis N, et al. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol. Jul 1 1999;211(1):100-8. [Medline].
20. Cachat F, Rapatsalahy A, Sekarski N, Hurni M, von Segesser L, Payot M. [Three different types of atrial septal defects in the same family]. Arch Mal Coeur Vaiss. May 1999;92(5):667-9. [Medline].
21. Cheng TO. Persistent left superior vena cava in Holt-Oram syndrome. Int J Cardiol. Oct 2000;76(1):83, 81-2. [Medline].
22. DuPre CT, Fincher RM. Holt-Oram syndrome associated with hypoplastic peripheral vasculature and midsystolic click. South Med J. Apr 1993;86(4):453-6. [Medline].
23. Ekure EN, Okoromah CN, Briggs E, Ajenifuja OA. Holt-Oram syndrome with hypoplastic left heart syndrome in an African child. Niger Postgrad Med J. Sep 2004;11(3):190-2. [Medline].
24. Fan C, Liu M, Wang Q. Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome. J Biol Chem. Mar 7 2003;278(10):8780-5. [Medline]. [Full Text].
25. Gruenauer-Kloevekorn C, Reichel MB, Duncker GI, Froster UG. Molecular genetic and ocular findings in patients with holt-oram syndrome. Ophthalmic Genet. Mar 2005;26(1):1-8. [Medline].
26. Hatcher CJ, Kim MS, Mah CS, et al. TBX5 transcription factor regulates cell proliferation during cardiogenesis. Dev Biol. Feb 15 2001;230(2):177-88. [Medline].
27. He J, McDermott DA, Song Y, et al. Preimplantation genetic diagnosis of human congenital heart malformation and Holt-Oram syndrome. Am J Med Genet A. Apr 1 2004;126(1):93-8.
28. Heinritz W, Moschik A, Kujat A, et al. Identification of new mutations in the TBX5 gene in patients with Holt-Oram syndrome. Heart. Mar 2005;91(3):383-4. [Medline]. [Full Text].
29. Heinritz W, Shou L, Moschik A, Froster UG. The human TBX5 gene mutation database. Hum Mutat. Oct 2005;26(4):397. [Medline].
30. Holt M, Oram S. Familial heart disease with skeletal malformations. Br Heart J. Apr 1960;22:236-42. [Medline].
31. Horb ME, Thomsen GH. Tbx5 is essential for heart development. Development. Apr 1999;126(8):1739-51. [Medline]. [Full Text].
32. Hurst JA, Hall CM, Baraitser M. The Holt-Oram syndrome. J Med Genet. Jun 1991;28(6):406-10. [Medline].
33. Keller BB. Developmental structure-function insights from Tbx5(del/+) mouse model of Holt-Oram syndrome. Am J Physiol Heart Circ Physiol. Sep 2005;289(3):H975-6. [Medline]. [Full Text].
34. Kohlhase J, Chitayat D, Kotzot D, et al. SALL4 mutations in Okihiro syndrome (Duane-radial ray syndrome), acro-renal-ocular syndrome, and related disorders. Hum Mutat. Sep 2005;26(3):176-83. [Medline].
35. Koishizawa T, Hayashi N, Tadokoro M, et al. [A case report of the radical correction of a truncus arteriosus and peripheral pulmonary stenosis in association with Holt-Oram syndrome]. Kyobu Geka. Feb 1995;48(2):133-6. [Medline].
36. Koutlas ED, Papageorgiou AA, Athyros VG. Holt-Oram syndrome with malformations of renal and cerebral arteries. Acta Cardiol. 1996;51(4):373-6. [Medline].
37. Le Meur N, Goldenberg A, Michel-Adde C, et al. Molecular characterization of a 14q deletion in a boy with features of Holt-Oram syndrome. Am J Med Genet A. May 1 2005;134(4):439-42. [Medline].
38. Lee ML, Tsao LY, Wang YM. Interventional cardiac catheterization for the coarctation of the aortic arch and patent ductus arteriosus in a 3-day-old neonate with the Holt-Oram syndrome. Int J Cardiol. Jun 8 2005;101(3):503-5. [Medline].
39. Lehner R, Goharkhay N, Tringler B, et al. Pedigree analysis and descriptive investigation of three classic phenotypes associated with Holt-Oram syndrome. J Reprod Med. Mar 2003;48(3):153-9. [Medline].
40. McDermott DA, Bressan MC, He J, et al. TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res. Nov 2005;58(5):981-6. [Full Text].
41. McDermott DA, He J, Song YS, et al. Update: PGD and Holt-Oram syndrome. Am J Med Genet A. Jul 15 2005;136(2):223. [Medline].
42. Moskowitz IP, Pizard A, Patel VV, et al. The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development. Aug 2004;131(16):4107-16. [Medline]. [Full Text].
43. Murakami M, Nakagawa M, Olson EN, Nakagawa O. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci U S A. Dec 13 2005;102(50):18034-9. [Medline]. [Full Text].
44. Newbury-Ecob RA, Leanage R, Raeburn JA, Young ID. Holt-Oram syndrome: a clinical genetic study. J Med Genet. Apr 1996;33(4):300-7. [Medline].
45. Pizard A, Burgon PG, Paul DL, et al. Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum. Mol Cell Biol. Jun 2005;25(12):5073-83. [Medline]. [Full Text].
46. Plageman TF, Yutzey KE. Microarray analysis of Tbx5-induced genes expressed in the developing heart. Dev Dyn. Oct 2006;235(10):2868-80. [Medline].
47. Porsch M, Hofmeyer K, Bausenwein BS, et al. Isolation of a Drosophila T-box gene closely related to human TBX1. Gene. Jun 8 1998;212(2):237-48. [Medline].
48. Schneider MD, Schwartz RJ. Heart or hand? Unmasking the basis for specific Holt-Oram phenotypes. Proc Natl Acad Sci U S A. Mar 16 1999;96(6):2577-8. [Medline]. [Full Text].
49. Shono S, Higa K, Kumano K, Dan K. Holt-Oram syndrome. Br J Anaesth. Jun 1998;80(6):856-7. [Medline]. [Full Text].
50. Sinkovec M, Petrovic D, Volk M, Peterlin B. Familial progressive sinoatrial and atrioventricular conduction disease of adult onset with sudden death, dilated cardiomyopathy, and brachydactyly. A new type of heart-hand syndrome?. Clin Genet. Aug 2005;68(2):155-60. [Medline].
51. Smets K, Mortier G, Zecic A. Perinatal/neonatal case presentation: unexpected severe respiratory insufficiency in a newborn with Holt-Oram Syndrome. J Perinatol. Nov 2005;25(11):745-6. [Medline].
52. Terrett JA, Newbury-Ecob R, Smith NM, et al. A translocation at 12q2 refines the interval containing the Holt-Oram syndrome 1 gene. Am J Hum Genet. Dec 1996;59(6):1337-41. [Medline].
53. Tucker KJ, Murphy J, Conti JB, Curtis AB. Syncope and sinus arrest associated with the upper limb-cardiovascular (Holt-Oram) syndrome. Pacing Clin Electrophysiol. Oct 1994;17(10):1678-80. [Medline].
54. Weber M, Wenz W, van Riel A, et al. [The Holt-Oram syndrome. Review of the literature and current orthopedic treatment concepts]. Z Orthop Ihre Grenzgeb. Jul-Aug 1997;135(4):368-75. [Medline].
55. Wilson GN. Correlated heart/limb anomalies in Mendelian syndromes provide evidence for a cardiomelic developmental field. Am J Med Genet. Apr 1 1998;76(4):297-305. [Medline].
56. Yi CH, Terrett JA, Li QY, et al. Identification, mapping, and phylogenomic analysis of four new human members of the T-box gene family: EOMES, TBX6, TBX18, and TBX19. Genomics. Jan 1 1999;55(1):10-20. [Medline].
57. Zaragoza MV, Lewis LE, Sun G, et al. Identification of the TBX5 transactivating domain and the nuclear localization signal. Gene. Apr 14 2004;330:9-18. [Medline].
58. Zhou YQ, Zhu Y, Bishop J, et al. Abnormal cardiac inflow patterns during postnatal development in a mouse model of Holt-Oram syndrome. Am J Physiol Heart Circ Physiol. Sep 2005;289(3):H992-H1001. [Medline]. [Full Text].

Article Last Updated: Nov 7, 2008